Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression
This study is investigating a new treatment for people with depression that hasn't gotten better with standard medications or therapy. We call this 'treatment-resistant depression'. The treatment involves a special device called the Next Generation Dome Helmet (NGDH), which uses focused ultrasound. Think of it like very gentle, targeted sound waves that can influence certain areas of the brain linked to mood. The main goals are to check if this treatment is safe for people to use and if it can help improve their depression. About 20 people will take part, receiving two treatment sessions and then having follow-up checks over a few weeks to see how they are doing.
At a glance
What is this study about?
This research is focused on helping people who live with severe depression that hasn't improved despite trying different types of treatments, such as antidepressant medications and talking therapies. This is often called 'treatment-resistant depression', and it can be very hard to live with.
The study is exploring a new approach using a device called the 'Next Generation Dome Helmet'. This helmet uses something called 'focused ultrasound neuromodulation'. Don't worry about the long words! Basically, it sends very precise, gentle sound waves to specific areas in the brain that are thought to be involved in controlling mood. The idea is that by gently influencing these brain areas, we might be able to help improve the symptoms of depression.
We really want to understand if this new treatment is safe for people and if it shows any signs of being effective in reducing depression symptoms. This is an early-stage study, meaning we're taking the first steps to learn about this new method in a small group of people.
Key takeaways
- This study explores a new treatment for severe depression that hasn't responded to other therapies.
- It uses a special helmet to deliver gentle sound waves to specific brain areas.
- The main goals are to check for safety and potential effectiveness.
- Participation involves two treatment sessions and several follow-up checks.
- You would continue your existing depression medications during the study.
- It's an early-stage study, so benefits are not guaranteed.
Who may be eligible?
To join this study, you need to be an adult between 18 and 65 years old and have a diagnosis of major depression that hasn't responded to at least two different antidepressant medications and at least six weeks of talking therapy like CBT. It's important that your current medications have been stable for at least a month.
There are also some reasons why you might not be able to join. For example, if you are pregnant or planning to become pregnant, or if you have certain other health conditions like an active seizure disorder or other serious medical illnesses. This study also involves MRI scans, so you couldn't participate if you have something in your body that isn't safe for an MRI, like certain types of pacemakers.
We also need to make sure you can reliably attend all the scheduled appointments for screening, treatment, and follow-up. If you have severe claustrophobia that would make getting an MRI scan difficult, you might not be suitable for this study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 65 years old?
- Do you have severe depression that hasn't improved with at least two antidepressants and talking therapy?
- Have your current medications been stable for at least a month?
- Are you able to attend all study appointments reliably?
- Are you NOT pregnant and don't plan to become pregnant during the study?
- Do you NOT have conditions that would make an MRI scan unsafe (e.g., certain pacemakers)?
What does participation involve?
If you join this study, you would first have a screening appointment with a study doctor and coordinator to check if the study is right for you. If you are eligible, you would then have two main treatment sessions with the special helmet. These sessions would be about four weeks apart.
After each treatment session, you would return for follow-up visits. These visits typically happen 24 hours, 2 weeks, and 4 weeks after each treatment. During these follow-up visits, the study team will use questionnaires and sometimes imaging scans to see how you're feeling and to check for any changes or side effects. You would continue to take your usual psychiatric medications as prescribed throughout the study. The total time you'd be involved in the study would be over several weeks or months, depending on when your treatments are scheduled and your follow-up visits are completed.
Potential risks and benefits
Locations (1)
- Sunnybrook Health Sciences CentreVerified postcodeToronto, Canada· Recruiting
Common questions
What is 'treatment-resistant depression'?
This is when someone's depression hasn't gotten better after trying different standard treatments, like antidepressant medications and talking therapies.
What is the 'Next Generation Dome Helmet'?
It's a special device used in this study that sends very precise, gentle sound waves to specific areas of the brain to try and help with depression.
Will I need to stop my current medications?
No, you'll continue with your usual prescribed psychiatric medications throughout the study. They should be stable for at least 30 days before joining.
How many treatments will I receive?
You would have two main treatment sessions, spaced about four weeks apart.
What are MRI scans for?
MRI scans help us to accurately target the treatment and also to monitor what's happening in the brain before and after the treatment.
How to find out more
Nir Lipsman, MD, PhD, FRCSC
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.